You can access any of the podium or poster presentations’ abstracts by searching for it below. For the 2026 FIP world congress in Montreal, presentations and summaries from invited speakers are available below, while abstracts are published in the Pharmacy Education Journal (PEJ) here.
Export this Abstract | Print this Abstract |
Add to my preferred Abstracts list |
My preferred Abstracts list (0) |
Back to Search
A rational approach to evaluation of therapeutic equivalence of nanosimilars: a challenge for formulary selection
- In: Poster presentation
- At: Seoul (South Korea) (2017)
- Type: Poster
- Poster code: POS-HPS-048
- By: FLüHMANN, Beat (., Zürich, Switzerland)
- Co-author(s): Beat Flühmann:
Stefan Mühlebach: Regulatory Science, Vifor Pharma Ltd, Zürich, Switzerland - Abstract:
Background
Today up to 23 nanomedicines are approved, and approximately 50 are in clinical development. First nanosimilars have entered the European market through the generic approval pathway, but significant clinical differences have been observed. Many hospital pharmacists are unaware of the specific characteristics of nanomedicines and the.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 23 September 2026